Riociguat is primarily indicated for the management of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). A recent phase 2b RISE-SSc trial, published …
A recent study published in the New England Journal of Medicine revealed that once-weekly injections of semaglutide significantly reduced both body weight and knee pain …
Groundbreaking research published in Life Science Alliance unveiled BTB domain and CNC homology 1 (BACH1) as a master regulator of destructive cell behavior in rheumatoid …
In a groundbreaking systematic review and meta-analysis, researchers revealed compelling evidence supporting the efficacy and safety profile of iguratimod (IGU) in treating ankylosing spondylitis (AS). …
A recent study published in the Rheumatic and Musculoskeletal Diseases Open has highlighted the potential role of specific serum biomarker ratios in enhancing diagnostic accuracy …
A groundbreaking study published in International Immunopharmacology has revealed that serum levels of High Mobility Group Box Protein-1 (HMGB-1), a multifunctional protein, could serve as …
A recent clinical trial published in Alternative Therapies in Health and Medicines has highlighted the potential benefits of pirfenidone for treating nonspecific interstitial pneumonia (NSIP) …
Rheumatologists and researchers have long sought better biomarkers for diagnosing and predicting the progression of systemic sclerosis (SSc). A recent study has identified anti-protein arginine …
A long-term study published in Rheumatology (Oxford) has confirmed the efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis (RA) who had inadequate responses to …